Latest Breaking News On - Refractory diffuse largeb cell lymphoma - Page 2 : vimarsana.com

SELLAS Life Sciences Reports Full Year 2023 Financial Results and Provides Corporate Update

SELLAS Life Sciences Reports Full Year 2023 Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesAngelos stergiouBruce mackleSteering committeeDrug administrationMemorial sloan kettering cancer centerPinternational gynecologic cancer societyNational cancer instituteEuropean school of haematologyLife sciences group incLifesci advisorsGenfleet therapeutics shanghai incCompany chemistryData monitoring committeeLife sciences reports full yearSciences reports full year

Genmab Announces Multiple Abstracts to be Presented at the 65th Annual Meeting and Exposition of the American Society of Hematology (ASH)

Genmab Announces Multiple Abstracts to be Presented at the 65th Annual Meeting and Exposition of the American Society of Hematology (ASH)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesNew jerseyUnited kingdomSan diegoKalvebod bryggeDavid freundelHematol hemoterAndrew carlsenJudith klimovskyOutcomes researchAbbvie biotechnology ltdCompany announcementNational comprehensive cancer networkData from the observational national lymphocare studyDiscovery researchAmerican society of hematology

MorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2023 ASH Annual Meeting

MorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2023 ASH Annual Meeting
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoTim demuthEamonn nolanJulia neugebauerThomas biegiConstellation pharmaceuticals incXencor incHilton bayfront hotelDrug administrationDevelopment officerExchange commissionAmerican society of hematologyLymphoma societySys to showcase phaseOral presentation

Gilead and Kite Oncology Present Data Demonstrating Car T-cell Therapy Survival Benefit and Showcasing Latest Advances in Blood Cancer Portfolio at ASH 2023

Gilead and Kite Oncology Present Data Demonstrating Car T-cell Therapy Survival Benefit and Showcasing Latest Advances in Blood Cancer Portfolio at ASH 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesFoster cityJacquie rossBrexucabtagene autoleucelMeaghan smithFrank neumannAnna padulaSanta monicaAxicabtagene ciloleucelVivo coGilead sciences incGilead public affairsMemorial sloan kettering cancer centerGilead sciencesLarge us health systemAmerican society of hematology

MorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at

EQS-News: MorphoSys AG / Key word(s): MiscellaneousMorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2023 ASH Annual Meeting 02.11.2023 / 14:05 CET/CESTThe issuer is solely responsible for the content of this announcement.Media ReleasePlanegg/Munich, Germany, Novemb.

United statesSan diegoJulia neugebauerThomas biegiEamonn nolanTim demuthDevelopment officerHilton bayfront hotelXencor incDistribution servicesLymphoma societyDrug administrationExchange commissionAmerican society of hematologyConstellation pharmaceuticals incSys to showcase phase